73
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting

, , , , , & show all
Pages 493-499 | Published online: 04 Dec 2013

References

  • MoayyediPDelaneyBCVakilNFormanDTalleyNJThe efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysisGastroenterology200412751329133715521002
  • HillmanLCChiragakisLShadboltBKayeGLClarkeACProton-pump inhibitor therapy and the development of dysplasia in patients with Barrett’s oesophagusMed J Aust2004180838739115089728
  • EdwardsSJLindTLundellLDasRSystematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis – a mixed treatment comparison of randomized controlled trialsAliment Pharmacol Ther200930654755619558609
  • DonnellanCSharmaNPrestonCMoayyediPMedical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux diseaseCochrane Database Syst Rev20052CD00324515846653
  • CremoniniFWiseJMoayyediPTalleyNJDiagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysisAm J Gastroenterol200510061226123215929749
  • LööfLGötellPElfbergBThe incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in SwedenScand J Gastroenterol19932821131188441904
  • ValleCBrogliaFPistorioATinelliCPeregoMPrevalence and impact of symptoms suggestive of gastroesophageal reflux diseaseDig Dis Sci19994491848185210505724
  • SontagSJSonnenbergASchnellTGLeyaJMetzAThe long-term natural history of gastroesophageal reflux diseaseJ Clin Gastroenterol200640539840416721220
  • DentJEl-SeragHBWallanderMAJohanssonSEpidemiology of gastro-oesophageal reflux disease: a systematic reviewGut200554571071715831922
  • MehtaSBennettJMahonDRhodesMProspective trial of laparoscopic nissen fundoplication versus proton pump inhibitor therapy for gastroesophageal reflux disease: Seven-year follow-upJ Gastrointest Surg200610913121316 discussion 1316–131717114017
  • MahonDRhodesMDecadtBRandomized clinical trial of laparoscopic Nissen fundoplication compared with proton-pump inhibitors for treatment of chronic gastro-oesophageal refluxBr J Surg200592669569915898130
  • SpechlerSJLeeEAhnenDLong-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trialJAMA2001285182331233811343480
  • LundellLMiettinenPMyrvoldHENordic GERD Study GroupComparison of outcomes twelve years after antireflux surgery or omeprazole maintenance therapy for reflux esophagitisClin Gastroenterol Hepatol200971212921298 quiz 126019490952
  • AnvariMAllenCMarshallJA randomized controlled trial of laparoscopic nissen fundoplication versus proton pump inhibitors for treatment of patients with chronic gastroesophageal reflux disease: One-year follow-upSurg Innov200613423824917227922
  • LundellLAttwoodSEllCLOTUS trial collaboratorsComparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trialGut20085791207121318469091
  • IMS Health IncorporatedTop 20 Global Therapeutic Classes, 2010, Toal Audited MarketsDanbury, CTIMS Health Incorporated2010 Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/Top_20_Global_Therapy_Classes.pdfAccessed September 16, 2013
  • NardinoRJVenderRJHerbertPNOveruse of acid-suppressive therapy in hospitalized patientsAm J Gastroenterol200095113118312211095327
  • BatuwitageBTKinghamJGMorganNEBartlettRLInappropriate prescribing of proton pump inhibitors in primary carePostgrad Med J200783975666817267683
  • LaineLHennekensCProton pump inhibitor and clopidogrel interaction: fact or fiction?Am J Gastroenterol20101051344119904241
  • ThomsonABSauveMDKassamNKamitakaharaHSafety of the long-term use of proton pump inhibitorsWorld J Gastroenterol201016192323233020480516
  • JohnsonDASafety of proton pump inhibitors: current evidence for osteoporosis and interaction with antiplatelet agentsCurr Gastroenterol Rep201012316717420425476
  • TepešBLong-term acid inhibition: benefits and harmsDig Dis201129547648122095013
  • O’DonoghueMLBraunwaldEAntmanEMPharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trialsLancet2009374969498999719726078
  • TargownikLELixLMMetgeCJPriorHJLeungSLeslieWDUse of proton pump inhibitors and risk of osteoporosis-related fracturesCMAJ2008179431932618695179
  • KhaliliHHuangESJacobsonBCCarmargoCAJrFeskanichDChanATUse of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort studyBMJ2012344e37222294756
  • HampelHAbrahamNSEl-SeragHBMeta-analysis: obesity and the risk for gastroesophageal reflux disease and its complicationsAnn Intern Med2005143319921116061918
  • WajedSAStreetsCGBremnerCGDeMeesterTRElevated body mass disrupts the barrier to gastroesophageal refluxArch Surg200113691014101911529823
  • LockeGR3rdTalleyNJFettSLZinsmeisterARMeltonLJ3rdRisk factors associated with symptoms of gastroesophageal refluxAm J Med1999106664264910378622
  • OliveriaSAChristosPJTalleyNJDannenbergAJHeartburn risk factors, knowledge, and prevention strategies: a population-based survey of individuals with heartburnArch Intern Med1999159141592159810421282
  • StanghelliniVThree-month prevalence rates of gastrointestinal symptoms and the influence of demographic factors: results from the Domestic/International Gastroenterology Surveillance Study (DIGEST)Scand J Gastroenterol Suppl1999231202810565620
  • MurrayLJohnstonBLaneARelationship between body mass and gastro-oesophageal reflux symptoms: The Bristol Helicobacter ProjectInt J Epidemiol200332464565012913045
  • NilssonMJohnsenRYeWHveemKLagergrenJObesity and estrogen as risk factors for gastroesophageal reflux symptomsJAMA20032901667212837713
  • ZhengZNordenstedtHPedersenNLLagergrenJYeWLifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twinsGastroenterology20071321879517241862
  • NoconMLabenzJWillichSNLifestyle factors and symptoms of gastro-oesophageal reflux – a population-based studyAliment Pharmacol Ther200623116917416393294
  • VitaleGCCheadleWGPatelBSadekSAMichelMECuschieriAThe effect of alcohol on nocturnal gastroesophageal refluxJAMA198725815207720793656623
  • KahrilasPJGuptaRRMechanisms of acid reflux associated with cigarette smokingGut19903114102318431
  • NilssonMJohnsenRYeWHveemKLagergrenJLifestyle related risk factors in the aetiology of gastro-oesophageal refluxGut200453121730173515542505
  • LarsenFBHvordan har du det? Selvvurderet helbred og ulighed i sundhed [How are you? Self-rated health and social inequality in health]AarhusUnit of Health Promotion, Department of Public Health2003
  • Health DNBoDanish National Board of Health2011 Available at: http://www.sst.dk/Sundhed%20og%20forebyggelse/Alkohol.aspxAccessed October 10, 2013
  • PedersenCBGøtzscheHMøllerJOMortensenPBThe Danish Civil Registration System. A cohort of eight million personsDan Med Bull2006534441449 Available from: http://www.whocc.no/atc_ddd_index/Accessed October 10, 201317150149
  • World Health OrganizationATC/DDD ClassificationWHO Drug Information2001158488 Available from: http://www.whocc.no/atc_ddd_index/Accessed October 10, 2013
  • World Health OrganizationInternational Statistical Classification of Diseases and Related Health Problems 10th Revision Available from: http://apps.who.int/classifications/icd10/browse/2010/enAccessed October 10, 2013
  • LyngeESandegaardJLReboljMThe Danish National Patient RegisterScand J Public Health201139Suppl 7303321775347
  • CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733833558716
  • RaghunathASHunginAPMasonJJacksonWSymptoms in patients on long-term proton pump inhibitors: prevalence and predictorsAliment Pharmacol Ther200929443143919035981
  • KayeJAJickHProton pump inhibitor use and risk of hip fractures in patients without major risk factorsPharmacotherapy200828895195918657011
  • MoayyediPTalleyNJGastro-oesophageal reflux diseaseLancet200636795282086210016798392
  • LagergrenJBergströmRNyrénONo relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based studyGut2000471262910861260
  • MeiningAClassenMThe role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux diseaseAm J Gastroenterol200095102692269711051337
  • NandurkarSLockeGR3rdFettSRelationship between body mass index, diet, exercise and gastro-oesophageal reflux symptoms in a communityAliment Pharmacol Ther200420549750515339321
  • DoreMPMaragkoudakisEFraleyKDiet, lifestyle and gender in gastro-esophageal reflux diseaseDig Dis Sci20085382027203218030622
  • El-SeragHBSatiaJARabeneckLDietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteersGut2005541111715591498
  • HansenJMWildner-ChristensenMSchaffalitzky de MuckadellOBGastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care useAm J Gastroenterol2009104102394240319623171
  • Hvid-JensenFPedersenLMunkEMDrewesAMFunch-JensenPLong-term complications to reflux disease in community practice. A 17-year cohort study of 4706 patientsScand J Gastroenterol201146101179118621793632
  • RonkainenJAroPStorskrubbTGastro-oesophageal reflux symptoms and health-related quality of life in the adult general population – the Kalixanda studyAliment Pharmacol Ther200623121725173316817916